{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:37:34Z","timestamp":1768325854003,"version":"3.49.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,5,2]],"date-time":"2009-05-02T00:00:00Z","timestamp":1241222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s11764-009-0083-4","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T20:10:44Z","timestamp":1241467844000},"page":"75-88","source":"Crossref","is-referenced-by-count":53,"title":["Skeletal sequelae of cancer and cancer treatment"],"prefix":"10.1007","volume":"3","author":[{"given":"Charles J.","family":"Stava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi I.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"Vassilopoulou-Sellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,2]]},"reference":[{"key":"83_CR1","unstructured":"NCI.SEER Cancer Statistics Review, 1975\u20132005. 2007; Available from: http:\/\/seer.cancer.gov\/csr\/1975_2005\/ ."},{"key":"83_CR2","volume-title":"From cancer patient to cancer survivor, lost in transition","author":"MGS Hewitt","year":"2006","unstructured":"Hewitt MGS, Stovall E. From cancer patient to cancer survivor, lost in transition. 1st ed. Washington, DC: National Academies; 2006.","edition":"1"},{"issue":"4","key":"83_CR3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ijc.10981","volume":"104","author":"PN Schultz","year":"2003","unstructured":"Schultz PN, Beck ML, Stava C, Vassilopoulou-Sellin R. Health profiles in 5836 long-term cancer survivors. Int J Cancer. 2003;104(4):488\u201395. doi: 10.1002\/ijc.10981 .","journal-title":"Int J Cancer"},{"issue":"2","key":"83_CR4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2702.2004.01030.x","volume":"14","author":"PN Schultz","year":"2005","unstructured":"Schultz PN, Klein MJ, Beck ML, Stava C, Sellin RV. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J Clin Nurs. 2005;14(2):204\u201311. doi: 10.1111\/j.1365-2702.2004.01030.x .","journal-title":"J Clin Nurs"},{"issue":"1","key":"83_CR5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cncr.11897","volume":"100","author":"PN Schultz","year":"2004","unstructured":"Schultz PN, Stava C, Beck ML, Vassilopoulou-Sellin R. Ethnic\/racial influences on the physiologic health of cancer survivors. Cancer. 2004;100(1):156\u201364. doi: 10.1002\/cncr.11897 .","journal-title":"Cancer"},{"issue":"5","key":"83_CR6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hed.10217","volume":"25","author":"PN Schultz","year":"2003","unstructured":"Schultz PN, Stava C, Vassilopoulou-Sellin R. Health profiles and quality of life of 518 survivors of thyroid cancer. Head Neck. 2003;25(5):349\u201356. doi: 10.1002\/hed.10217 .","journal-title":"Head Neck"},{"issue":"6","key":"83_CR7","first-page":"1193","volume":"13","author":"C Stava","year":"2005","unstructured":"Stava C, Beck M, Schultz PN, Vassilopoulou-Sellin R. Hearing loss among cancer survivors. Oncol Rep. 2005;13(6):1193\u20139.","journal-title":"Oncol Rep"},{"issue":"6","key":"83_CR8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.coc.0000175291.51232.48","volume":"28","author":"C Stava","year":"2005","unstructured":"Stava C, Beck M, Vassilopoulou-Sellin R. Cataracts among cancer survivors. Am J Clin Oncol. 2005;28(6):603\u20138. doi: 10.1097\/01.coc.0000175291.51232.48 .","journal-title":"Am J Clin Oncol"},{"key":"83_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2407-6-95","volume":"6","author":"C Stava","year":"2006","unstructured":"Stava C, Beck M, Weiss LT, Lopez A, Vassilopoulou-Sellin R. Health profiles of 996 melanoma survivors: the M. D. Anderson experience. BMC Cancer. 2006;6:95. doi: 10.1186\/1471-2407-6-95 .","journal-title":"BMC Cancer"},{"issue":"3","key":"83_CR10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3816\/CBC.2006.n.034","volume":"7","author":"C Stava","year":"2006","unstructured":"Stava C, Weiss LT, Vassilopoulou-Sellin R. Health profiles of 814 very long-term breast cancer survivors. Clin Breast Cancer. 2006;7(3):228\u201336. doi: 10.3816\/CBC.2006.n.034 .","journal-title":"Clin Breast Cancer"},{"issue":"8","key":"83_CR11","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/cncr.22200","volume":"107","author":"CJ Stava","year":"2006","unstructured":"Stava CJ, Lopez A, Vassilopoulou\u2013Sellin R. Health profiles of younger and older breast cancer survivors. Cancer. 2006;107(8):1752\u20139. doi: 10.1002\/cncr.22200 .","journal-title":"Cancer"},{"key":"83_CR12","first-page":"102","volume":"1","author":"C Stava","year":"2007","unstructured":"Stava C, Beck M, Feng L, Lopez A, Busaidy N, Vassilopoulou-Sellin R. Diabetes mellitus among cancer survivors. Journal of Cancer Survivorship. 2007;1:102\u201315.","journal-title":"Journal of Cancer Survivorship"},{"issue":"7","key":"83_CR13","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","volume":"18","author":"J Pfeilschifter","year":"2000","unstructured":"Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol. 2000;18(7):1570\u201393.","journal-title":"J Clin Oncol"},{"issue":"5","key":"83_CR14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1078-1439(03)00109-1","volume":"21","author":"FA Conde","year":"2003","unstructured":"Conde FA, Aronson WJ. Risk factors for male osteoporosis. Urol Oncol. 2003;21(5):380\u20133. doi: 10.1016\/S1078-1439(03) 00109-1 .","journal-title":"Urol Oncol"},{"key":"83_CR15","unstructured":"National Osteoporosis Foundation.Osteoporosis: Fast Facts. 2007; Available from: http:\/\/www.nof.org\/osteoporosis\/diseasefacts.htm ."},{"issue":"5","key":"83_CR16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2146\/ajhp050045.p1","volume":"63","author":"LB Michaud","year":"2006","unstructured":"Michaud LB, Goodin S. Cancer-treatment-induced bone loss, part 1. Am J Health-Sys Pharm. 2006;63(5):419\u201330. doi: 10.2146\/ajhp050045.p1 .","journal-title":"Am J Health-Sys Pharm"},{"key":"83_CR17","unstructured":"World Health Organization.Prevention and Management of Osteoporosis: Report of a WHO Scientific Group (Technical Report Series 921). In A WHO Scientific Group on Prevention and Management of Osteoporosis. 2000. Geneva."},{"key":"83_CR18","first-page":"2389","volume-title":"Cancer medicine","author":"SC Yeung","year":"2000","unstructured":"Yeung SC, Gagel RF. Endocrine complications. In: Holland JF, Bast Jr RC, Kufe DW, Pollock RE, Weischelbaum RR, editors. Cancer medicine. Hamilton, Ontario: BC Decker; 2000. p. 2389\u201398."},{"issue":"2","key":"83_CR19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/edrv.19.2.0328","volume":"19","author":"SC Yeung","year":"1998","unstructured":"Yeung SC, Chiu AC, Vassilopoulou-Sellin R, Gagel RF. The endocrine effects of nonhormonal antineoplastic therapy. Endocr Rev. 1998;19(2):144\u201372. doi: 10.1210\/er.19.2.144 .","journal-title":"Endocr Rev"},{"issue":"4","key":"83_CR20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/02841860701218642","volume":"46","author":"LH Aksnes","year":"2007","unstructured":"Aksnes LH, Bruland OS. Some musculo-skeletal sequelae in cancer survivors. Acta Oncol (Stockholm, Sweden). 2007;46(4):490\u20136.","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"key":"83_CR21","unstructured":"Ottery F. Issues in nutrition, weight and cancer. US Oncol Rev, 2005, 2004."},{"issue":"9156","key":"83_CR22","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","volume":"353","author":"JR Center","year":"1999","unstructured":"Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353(9156):878\u201382. doi: 10.1016\/S0140-6736(98)09075-8 .","journal-title":"Lancet"},{"issue":"4","key":"83_CR23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11914-007-0013-1","volume":"5","author":"MI Hu","year":"2007","unstructured":"Hu MI, Gagel RF, Jimenez C. Bone loss in patients with breast or prostate cancer. Cur Osteoporos Rep. 2007;5(4):170\u20138.","journal-title":"Cur Osteoporos Rep"},{"issue":"2A","key":"83_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1083-8791(00)70039-5","volume":"6","author":"KN Weilbaecher","year":"2000","unstructured":"Weilbaecher KN. Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplantation. 2000;6(2A):165\u201374. doi: 10.1016\/S1083-8791(00)70039-5 .","journal-title":"Biol Blood Marrow Transplantation"},{"key":"83_CR25","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/jama.1941.02820220007002","volume":"116","author":"F Albright","year":"1941","unstructured":"Albright F, Smith P, Richardson AM. Postmenopausal Osteoporosis. JAMA. 1941;116:2465\u201374.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"83_CR26","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF02383388","volume":"12","author":"C Miyaura","year":"1994","unstructured":"Miyaura C. Mechanism of bone resorption induced by estrogen deficiency. J Bone and Miner Met. 1994;12(Suppl 2):S3\u20137. doi: 10.1007\/BF02383388 .","journal-title":"J Bone and Miner Met"},{"issue":"2","key":"83_CR27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-5347(01)65165-6","volume":"157","author":"HW Daniell","year":"1997","unstructured":"Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol. 1997;157(2):439\u201344. doi: 10.1016\/S0022-5347(01)65165-6 .","journal-title":"J Urol"},{"issue":"5","key":"83_CR28","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718\u201329.","journal-title":"J Clin Oncol"},{"key":"83_CR29","first-page":"2758","volume-title":"Cancer: principles & practice of oncology","author":"ML Meistrich","year":"1997","unstructured":"Meistrich ML, Vassilopoulou-Sellin R, Lipschultz L. Gonadal dysfunction: effects of cytotoxic agents on adult men. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles & practice of oncology. Philadelphia, PA: Williams & Wilkin; 1997. p. 2758\u201373."},{"issue":"11","key":"83_CR30","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","volume":"14","author":"C Bokemeyer","year":"1996","unstructured":"Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol. 1996;14(11):2923\u201332.","journal-title":"J Clin Oncol"},{"issue":"1","key":"83_CR31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2265.1997.2211032.x","volume":"47","author":"PF Collet-Solberg","year":"1997","unstructured":"Collet-Solberg PF, Sernyak H, Satin-Smith M, Katz LL, Sutton L, Molloy P, et al. Endocrine outcome in long-term survivors of low-grade hypothalamic\/chiasmatic glioma. Clin Endocrinol (Oxf). 1997;47(1):79\u201385. doi: 10.1046\/j.1365-2265.1997.2211032.x .","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"83_CR32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/02841860601166958","volume":"46","author":"M Brydoy","year":"2007","unstructured":"Brydoy M, Fossa SD, Dahl O, Bjoro T. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol (Stockholm, Sweden). 2007;46(4):480\u20139. doi: 10.1080\/02841860601166958 .","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"issue":"5","key":"83_CR33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/adc.63.5.495","volume":"63","author":"EA Livesey","year":"1988","unstructured":"Livesey EA, Brook CG. Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child. 1988;63(5):495\u2013500. doi: 10.1136\/adc.63.5.495 .","journal-title":"Arch Dis Child"},{"issue":"10","key":"83_CR34","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/1097-0142(20010515)91:10<1889::AID-CNCR1211>3.0.CO;2-U","volume":"91","author":"HW Daniell","year":"2001","unstructured":"Daniell HW, Clark JC, Pereira SE, Niazi ZA, Ferguson DW, Dunn SR, et al. Hypogonadism following prostate-bed radiation therapy for prostate carcinoma. Cancer. 2001;91(10):1889\u201395. doi: 10.1002\/1097-0142(20010515)91:10<1889::AID-CNCR1211>3.0.CO;2-U .","journal-title":"Cancer"},{"issue":"4","key":"83_CR35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-8529(05)70048-7","volume":"27","author":"S Howell","year":"1998","unstructured":"Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am. 1998;27(4):927\u201343. doi: 10.1016\/S0889-8529(05)70048-7 .","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"83_CR36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0022-5347(17)45831-9","volume":"135","author":"PW Grigsby","year":"1986","unstructured":"Grigsby PW, Perez CA. The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate. J Urol. 1986;135(4):726\u20137.","journal-title":"J Urol"},{"issue":"2","key":"83_CR37","first-page":"288","volume":"76","author":"D Goldray","year":"1993","unstructured":"Goldray D, Weisman Y, Jaccard N, Merdler C, Chen J, Matzkin H. Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist decapeptyl (D-Trp6-GnRH). J Clin Endocrinol Metab. 1993;76(2):288\u201390. doi: 10.1210\/jc.76.2.288 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"83_CR38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1096-9098(199702)64:2<167::AID-JSO16>3.0.CO;2-3","volume":"64","author":"TJ Garrett","year":"1997","unstructured":"Garrett TJ, Vahdat LT, Kinne DW. Systemic adjuvant therapy of breast cancer. J Surg Oncol;. 1997;64(2):167\u201372. doi: 10.1002\/(SICI) 1096-9098(199702)64:2<167::AID-JSO16>3.0.CO;2-3 .","journal-title":"J Surg Oncol;"},{"issue":"4","key":"83_CR39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0090-4295(99)00301-5","volume":"54","author":"JT Wei","year":"1999","unstructured":"Wei JT, Gross M, Jaffe CA, Gravlin K, Lahaie M, Faerber GJ, et al. Androgen deprivation therapy for prostate cancer results in significant loss of bone density. Urology. 1999;54(4):607\u201311. doi: 10.1016\/S0090-4295(99)00301-5 .","journal-title":"Urology"},{"issue":"6","key":"83_CR40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2002.01551.x","volume":"56","author":"S Basaria","year":"2002","unstructured":"Basaria S, Lieb J, Tang AM, DeWeese T, Carducci M, Eisenberger M, et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf). 2002;56(6):779\u201386. doi: 10.1046\/j.1365-2265.2002.01551.x .","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"83_CR41","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jcem.87.8.8782","volume":"87","author":"D Mittan","year":"2002","unstructured":"Mittan D, Lee S, Miller E, Perez RC, Basler JW, Bruder JM. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab. 2002;87(8):3656\u201361. doi: 10.1210\/jc.87.8.3656 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"83_CR42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/edrv-7-1-89","volume":"7","author":"A Manni","year":"1986","unstructured":"Manni A, Santen R, Harvey H, Lipton A, Max D. Treatment of breast cancer with gonadotropin-releasing hormone. Endocr Rev. 1986;7(1):89\u201394. doi: 10.1210\/edrv-7-1-89 .","journal-title":"Endocr Rev"},{"issue":"2","key":"83_CR43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000090956","volume":"52","author":"TJ Allain","year":"2006","unstructured":"Allain TJ. Prostate cancer, osteoporosis and fracture risk. Gerontology. 2006;52(2):107\u201310. doi: 10.1159\/000090956 .","journal-title":"Gerontology"},{"issue":"5","key":"83_CR44","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncr.20056","volume":"100","author":"TH Diamond","year":"2004","unstructured":"Diamond TH, Higano CS, Smith MR, Guise TA, Singer FR. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer. 2004;100(5):892\u20139. doi: 10.1002\/cncr.20056 .","journal-title":"Cancer"},{"issue":"2","key":"83_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","volume":"352","author":"VB Shahinian","year":"2005","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005;352(2):154\u201364. doi: 10.1056\/NEJMoa041943 .","journal-title":"N Engl J Med"},{"issue":"21","key":"83_CR46","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1158\/1078-0432.CCR-06-1382","volume":"12","author":"JE Brown","year":"2006","unstructured":"Brown JE, Ellis SP, Silcocks P, Blumsohn A, Gutcher SA, Radstone C, et al. Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma. Clin Cancer Res. 2006;12(21):6480\u20136. doi: 10.1158\/1078-0432.CCR-06-1382 .","journal-title":"Clin Cancer Res"},{"issue":"1","key":"83_CR47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0090-4295(00)00895-5","volume":"57","author":"BJ Kiratli","year":"2001","unstructured":"Kiratli BJ, Srinivas S, Perkash I, Terris MK. Progressive decrease in bone density over 10\u00a0years of androgen deprivation therapy in patients with prostate cancer. Urology. 2001;57(1):127\u201332. doi: 10.1016\/S0090-4295(00)00895-5 .","journal-title":"Urology"},{"issue":"1","key":"83_CR48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-5347(05)00033-9","volume":"175","author":"MR Smith","year":"2006","unstructured":"Smith MR, Boyce SP, Moyneur E, Duh MS, Raut MK, Brandman J. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol. 2006;175(1):136\u20139. doi: 10.1016\/S0022-5347(05)00033-9 . discussion 139.","journal-title":"J Urol"},{"issue":"4","key":"83_CR49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0022-5347(01)61639-2","volume":"161","author":"JF Maillefert","year":"1999","unstructured":"Maillefert JF, Sibilia J, Michel F, Saussine C, Javier RM, Tavernier C. Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma. J Urol. 1999;161(4):1219\u201322. doi: 10.1016\/S0022-5347(01)61639-2 .","journal-title":"J Urol"},{"issue":"4","key":"83_CR50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5694\/j.1326-5377.2006.tb00180.x","volume":"184","author":"DJ Holmes-Walker","year":"2006","unstructured":"Holmes-Walker DJ, Woo H, Gurney H, Do VT, Chipps DR. Maintaining bone health in patients with prostate cancer. Med J Aust. 2006;184(4):176\u20139.","journal-title":"Med J Aust"},{"issue":"5","key":"83_CR51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00774-005-0618-3","volume":"23","author":"K Makita","year":"2005","unstructured":"Makita K, Ishitani K, Ohta H, Horiguchi F, Nozawa S. Long-term effects on bone mineral density and bone metabolism of 6\u00a0months\u2019 treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate. J Bone Miner Metab. 2005;23(5):389\u201394. doi: 10.1007\/s00774-005-0618-3 .","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"83_CR52","first-page":"243","volume":"35","author":"N McLeod","year":"2006","unstructured":"McLeod N, Huynh CC, Rashid P. Osteoporosis from androgen deprivation therapy in prostate cancer treatment. Aust Fam Physician. 2006;35(4):243\u20135.","journal-title":"Aust Fam Physician"},{"issue":"6","key":"83_CR53","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","volume":"30","author":"B Ramaswamy","year":"2003","unstructured":"Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol. 2003;30(6):763\u201375. doi: 10.1053\/j.seminoncol.2003.08.028 .","journal-title":"Semin Oncol"},{"issue":"2","key":"83_CR54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3816\/CBC.2006.n.021","volume":"7","author":"BA Mincey","year":"2006","unstructured":"Mincey BA, Duh MS, Thomas SK, Moyneur E, Marynchencko M, Boyce SP, et al. Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors. Clin Breast Cancer. 2006;7(2):127\u201332. doi: 10.3816\/CBC.2006.n.021 .","journal-title":"Clin Breast Cancer"},{"issue":"10","key":"83_CR55","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.11-10-1121","volume":"11","author":"TA Guise","year":"2006","unstructured":"Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist. 2006;11(10):1121\u201331. doi: 10.1634\/theoncologist.11-10-1121 .","journal-title":"Oncologist"},{"issue":"17","key":"83_CR56","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.ejca.2007.08.029","volume":"43","author":"EV McCloskey","year":"2007","unstructured":"McCloskey EV, Hannon RA, Lakner G, Fraser WD, Clack G, Miyamoto A, et al. Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women. Eur J Cancer. 2007;43(17):2523\u201331. doi: 10.1016\/j.ejca.2007.08.029 .","journal-title":"Eur J Cancer"},{"issue":"2","key":"83_CR57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jbspin.2003.02.001","volume":"71","author":"E Fontanges","year":"2004","unstructured":"Fontanges E, Fontana A, Delmas P. Osteoporosis and breast cancer. Joint Bone Spine. 2004;71(2):102\u201310. doi: 10.1016\/j.jbspin.2003.02.001 .","journal-title":"Joint Bone Spine"},{"issue":"13","key":"83_CR58","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","volume":"326","author":"RR Love","year":"1992","unstructured":"Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med. 1992;326(13):852\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"83_CR59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","volume":"14","author":"TJ Powles","year":"1996","unstructured":"Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol. 1996;14(1):78\u201384.","journal-title":"J Clin Oncol"},{"issue":"11","key":"83_CR60","first-page":"653","volume":"106","author":"SK Shah","year":"2006","unstructured":"Shah SK, Gecys GT. Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect. J Am Osteopath Assoc. 2006;106(11):653\u20137.","journal-title":"J Am Osteopath Assoc"},{"issue":"1","key":"83_CR61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.54.1.49","volume":"54","author":"C Cooper","year":"1995","unstructured":"Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995;54(1):49\u201352. doi: 10.1136\/ard.54.1.49 .","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"83_CR62","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2165\/00002018-200124080-00005","volume":"24","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Papaioannou A. Corticosteroid-Induced osteoporosis: detection and management. Drug Saf. 2001;24(8):607\u201324. doi: 10.2165\/00002018-200124080-00005 .","journal-title":"Drug Saf"},{"issue":"3","key":"83_CR63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jcem.83.3.4621","volume":"83","author":"G Pearce","year":"1998","unstructured":"Pearce G, Tabensky DA, Delmas PD, Baker HW, Seeman E. Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab. 1998;83(3):801\u20136. doi: 10.1210\/jc.83.3.801 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"83_CR64","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1097-0142(197003)25:3<580::AID-CNCR2820250313>3.0.CO;2-M","volume":"25","author":"AH Ragab","year":"1970","unstructured":"Ragab AH, Frech RS, Vietti TJ. Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer. 1970;25(3):580\u20135. doi: 10.1002\/1097-0142(197003)25:3<580::AID-CNCR2820250313>3.0.CO;2-M .","journal-title":"Cancer"},{"issue":"1","key":"83_CR65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00361126","volume":"11","author":"AM Schwartz","year":"1984","unstructured":"Schwartz AM, Leonidas JC. Methotrexate osteopathy. Skeletal Radiol. 1984;11(1):13\u20136. doi: 10.1007\/BF00361126 .","journal-title":"Skeletal Radiol"},{"issue":"2","key":"83_CR66","first-page":"101","volume":"48","author":"F Athanassiadou","year":"2006","unstructured":"Athanassiadou F, Tragiannidis A, Rousso I, Katsos G, Sidi V, Papageorgiou T, et al. Bone mineral density in survivors of childhood acute lymphoblastic leukemia. Turk J Pediatr. 2006;48(2):101\u20134.","journal-title":"Turk J Pediatr"},{"issue":"9","key":"83_CR67","first-page":"3121","volume":"83","author":"PM Crofton","year":"1998","unstructured":"Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab. 1998;83(9):3121\u20139. doi: 10.1210\/jc.83.9.3121 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"83_CR68","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4065\/79.12.1557","volume":"79","author":"RA Wermers","year":"2004","unstructured":"Wermers RA, Hurley DL, Kearns AE. Osteoporosis associated with megestrol acetate. Mayo Clin Proc. 2004;79(12):1557\u201361. doi: 10.4065\/79.12.1557 .","journal-title":"Mayo Clin Proc"},{"key":"83_CR69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.blo.0000073348.50837.f2","volume":"413","author":"BL Leeuwen Van","year":"2003","unstructured":"Van Leeuwen BL, Verkerke GJ, Hartel RM, Sluiter WJ, Kamps WA, Jansen HW, et al. Chemotherapy decreases epiphyseal strength and increases bone fracture risk. Clin Orthop Relat Res. 2003;413:243\u201354. doi: 10.1097\/01.blo.0000073348.50837.f2 .","journal-title":"Clin Orthop Relat Res"},{"issue":"9\u201310","key":"83_CR70","first-page":"1527","volume":"63","author":"DD Hoff Von","year":"1979","unstructured":"Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozencweig M, Young RC, et al. Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep. 1979;63(9\u201310):1527\u201331.","journal-title":"Cancer Treat Rep"},{"issue":"4 Pt 1","key":"83_CR71","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1203\/00006450-199904010-00014","volume":"45","author":"JT Warner","year":"1999","unstructured":"Warner JT, Evans WD, Webb DK, Bell W, Gregory JW. Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res. 1999;45(4 Pt 1):544\u201351. doi: 10.1203\/00006450-199904010-00014 .","journal-title":"Pediatr Res"},{"issue":"2","key":"83_CR72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000146262","volume":"127","author":"TM Wang","year":"1986","unstructured":"Wang TM, Shih C. Study of histomorphometric changes of the mandibular condyles in neonatal and juvenile rats after administration of cyclophosphamide. Acta Anat. 1986;127(2):93\u20139. doi: 10.1159\/000146262 .","journal-title":"Acta Anat"},{"issue":"3","key":"83_CR73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00223-004-0231-9","volume":"77","author":"F Mwale","year":"2005","unstructured":"Mwale F, Ciobanu I, Demers CN, Antoniou J, Heon S, Servant N, et al. Amifostine and dexrazoxane enhance the rapid loss of bone mass and further deterioration of vertebrae architecture in female rats. Calcif Tissue Int. 2005;77(3):175\u20139. doi: 10.1007\/s00223-004-0231-9 .","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"83_CR74","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00402-004-0732-z","volume":"124","author":"BL Leeuwen van","year":"2004","unstructured":"van Leeuwen BL, Hartel R, Jansen HW, Verkerke GJ, Veth RP, Kamps WA, et al. Chemotherapy affects the pattern of failure after shear loading of the proximal tibial growth plate. Arch Orthop Trauma Surg. 2004;124(8):503\u20136. doi: 10.1007\/s00402-004-0732-z .","journal-title":"Arch Orthop Trauma Surg"},{"issue":"2","key":"83_CR75","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1432-1033.1990.tb19377.x","volume":"193","author":"JN Beresford","year":"1990","unstructured":"Beresford JN, Taylor GT, Triffitt JT. Interferons and bone. A comparison of the effects of interferon-alpha and interferon-gamma in cultures of human bone-derived cells and an osteosarcoma cell line. Eur J Biochem. 1990;193(2):589\u201397. doi: 10.1111\/j.1432-1033.1990.tb19377.x .","journal-title":"Eur J Biochem"},{"key":"83_CR76","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-230X-5-30","volume":"5","author":"A Gur","year":"2005","unstructured":"Gur A, Dikici B, Nas K, Bosnak M, Haspolat K, Sarac AJ. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis? BMC Gastroenterol. 2005;5:30. doi: 10.1186\/1471-230X-5-30 .","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"83_CR77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S8756-3282(99)00182-9","volume":"25","author":"GR Goodman","year":"1999","unstructured":"Goodman GR, Dissanayake IR, Gorodetsky E, Zhou H, Ma YF, Jee WS, et al. Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the rat. Bone. 1999;25(4):459\u201363. doi: 10.1016\/S8756-3282(99)00182-9 .","journal-title":"Bone"},{"issue":"5","key":"83_CR78","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(00)80314-1","volume":"33","author":"JA Solis-Herruzo","year":"2000","unstructured":"Solis-Herruzo JA, Castellano G, Fernandez I, Munoz R, Hawkins F. Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C. J Hepatol. 2000;33(5):812\u20137. doi: 10.1016\/S0168-8278(00)80314-1 .","journal-title":"J Hepatol"},{"issue":"10","key":"83_CR79","doi-asserted-by":"crossref","first-page":"901","DOI":"10.33588\/rn.3610.2002555","volume":"36","author":"JL Perez Castrillon","year":"2003","unstructured":"Perez Castrillon JL, Cano-del Pozo M, Sanz-Izquierdo S, Velayos-Jimenez J, Dib-Wobakin W. Bone mineral density in patients with multiple sclerosis: the effects of interferon. Rev Neurol. 2003;36(10):901\u20133.","journal-title":"Rev Neurol"},{"issue":"9","key":"83_CR80","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/35.9.898","volume":"35","author":"T Lehmann","year":"1996","unstructured":"Lehmann T, Beyeler C, Lammle B, Hunziker T, Vock P, Olah AJ, et al. Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B. Br J Rheumatol. 1996;35(9):898\u2013900. doi: 10.1093\/rheumatology\/35.9.898 .","journal-title":"Br J Rheumatol"},{"issue":"5","key":"83_CR81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.genhosppsych.2005.03.008","volume":"27","author":"A Waheed","year":"2005","unstructured":"Waheed A, Kettl PA. Low bone density with the use of valproate. Gen Hosp Psychiatry. 2005;27(5):376\u20138. doi: 10.1016\/j.genhosppsych.2005.03.008 .","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"83_CR82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.57.3.445","volume":"57","author":"Y Sato","year":"2001","unstructured":"Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001;57(3):445\u20139.","journal-title":"Neurology"},{"issue":"4","key":"83_CR83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pediatrneurol.2004.03.021","volume":"31","author":"C Ecevit","year":"2004","unstructured":"Ecevit C, Aydogan A, Kavakli T, Altinoz S. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol. 2004;31(4):279\u201382. doi: 10.1016\/j.pediatrneurol.2004.03.021 .","journal-title":"Pediatr Neurol"},{"issue":"2","key":"83_CR84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-3476(95)70304-7","volume":"127","author":"RD Sheth","year":"1995","unstructured":"Sheth RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr. 1995;127(2):256\u201362. doi: 10.1016\/S0022-3476(95) 70304-7 .","journal-title":"J Pediatr"},{"issue":"5","key":"83_CR85","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1046\/j.1523-1755.1999.00445.x","volume":"55","author":"AM Cueto-Manzano","year":"1999","unstructured":"Cueto-Manzano AM, Konel S, Hutchison AJ, Crowley V, France MW, Freemont AJ, et al. Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int. 1999;55(5):2021\u20139. doi: 10.1046\/j.1523-1755.1999.00445.x .","journal-title":"Kidney Int"},{"issue":"5","key":"83_CR86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2001.v7.pm11400947","volume":"7","author":"JM Stern","year":"2001","unstructured":"Stern JM, Sullivan KM, Ott SM, Seidel K, Fink JC, Longton G, et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant. 2001;7(5):257\u201364. doi: 10.1053\/bbmt.2001.v7.pm11400947 .","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"83_CR87","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1359\/jbmr.1999.14.3.342","volume":"14","author":"PR Ebeling","year":"1999","unstructured":"Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res. 1999;14(3):342\u201350. doi: 10.1359\/jbmr.1999.14.3.342 .","journal-title":"J Bone Miner Res"},{"issue":"Suppl 21","key":"83_CR88","first-page":"S93","volume":"18","author":"PN Sambrook","year":"2000","unstructured":"Sambrook PN. Cyclosporine and bone mass. Clin Exp Rheumatol. 2000;18(Suppl 21):S93\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"83_CR89","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.bmt.1704618","volume":"34","author":"K Kerschan-Schindl","year":"2004","unstructured":"Kerschan-Schindl K, Mitterbauer M, Fureder W, Kudlacek S, Grampp S, Bieglmayer C, et al. Bone metabolism in patients more than five years after bone marrow transplantation. Bone Marrow Transplant. 2004;34(6):491\u20136. doi: 10.1038\/sj.bmt.1704618 .","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"83_CR90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00002018-200730010-00004","volume":"30","author":"B Bannwarth","year":"2007","unstructured":"Bannwarth B. Drug-induced musculoskeletal disorders. Drug Saf. 2007;30(1):27\u201346. doi: 10.2165\/00002018-200730010-00004 .","journal-title":"Drug Saf"},{"issue":"12","key":"83_CR91","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1345\/aph.1G028","volume":"39","author":"HA Jackson","year":"2005","unstructured":"Jackson HA, Sheehan AH. Effect of vitamin A on fracture risk. Ann Pharmacother. 2005;39(12):2086\u201390. doi: 10.1345\/aph.1G028 .","journal-title":"Ann Pharmacother"},{"issue":"10","key":"83_CR92","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-129-10-199811150-00003","volume":"129","author":"H Melhus","year":"1998","unstructured":"Melhus H, Michaelsson K, Kindmark A, Bergstrom R, Holmberg L, Mallmin H, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med. 1998;129(10):770\u20138.","journal-title":"Ann Intern Med"},{"issue":"11","key":"83_CR93","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1359\/jbmr.1997.12.11.1844","volume":"12","author":"H Saino","year":"1997","unstructured":"Saino H, Matsuyama T, Takada J, Kaku T, Ishii S. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats. J Bone Miner Res. 1997;12(11):1844\u201350. doi: 10.1359\/jbmr.1997.12.11.1844 .","journal-title":"J Bone Miner Res"},{"issue":"8","key":"83_CR94","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5435\/00124635-200708000-00002","volume":"15","author":"SB Goodman","year":"2007","unstructured":"Goodman SB, Jiranek W, Petrow E, Yasko AW. The effects of medications on bone. J Am Acad Orthop Surg. 2007;15(8):450\u201360.","journal-title":"J Am Acad Orthop Surg"},{"issue":"4","key":"83_CR95","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S8756-3282(00)00361-6","volume":"27","author":"TP Staa van","year":"2000","unstructured":"van Staa TP, Leufkens HG, Cooper C. Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone. 2000;27(4):563\u20138. doi: 10.1016\/S8756-3282(00)00361-6 .","journal-title":"Bone"},{"issue":"2","key":"83_CR96","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2185\/jjrm.50.96","volume":"50","author":"SK Kumaki","year":"2001","unstructured":"Kumaki SK. H. Effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on osteoporosis. J Jpn Assoc Rural Med. 2001;50(2):96\u2013101.","journal-title":"J Jpn Assoc Rural Med"},{"issue":"10","key":"83_CR97","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1359\/jbmr.2003.18.10.1795","volume":"18","author":"LD Carbone","year":"2003","unstructured":"Carbone LD, Tylavsky FA, Cauley JA, Harris TB, Lang TF, Bauer DC, et al. Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res. 2003;18(10):1795\u2013802. doi: 10.1359\/jbmr.2003.18.10.1795 .","journal-title":"J Bone Miner Res"},{"issue":"1","key":"83_CR98","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jbmr.5650110106","volume":"11","author":"DC Bauer","year":"1996","unstructured":"Bauer DC, Orwoll ES, Fox KM, Vogt TM, Lane NE, Hochberg MC, et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1996;11(1):29\u201335.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"83_CR99","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0959-8049(94)90287-9","volume":"30A","author":"T Taube","year":"1994","unstructured":"Taube T, Kylmala T, Lamberg-Allardt C, Tammela TL, Elomaa I. The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study. Eur J Cancer. 1994;30A(6):751\u20138. doi: 10.1016\/0959-8049(94)90287-9 .","journal-title":"Eur J Cancer"},{"issue":"10","key":"83_CR100","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/1097-0142(19861115)58:10<2208::AID-CNCR2820581008>3.0.CO;2-A","volume":"58","author":"DL Citrin","year":"1986","unstructured":"Citrin DL, Wallemark CB, Nadler R, Geiger C, Tuttle K, Kaplan EH, et al. Estramustine affects bone mineral metabolism in metastatic prostate cancer. Cancer. 1986;58(10):2208\u201313. doi: 10.1002\/1097-0142(19861115)58:10<2208::AID-CNCR2820581008>3.0.CO;2-A .","journal-title":"Cancer"},{"issue":"3","key":"83_CR101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00198-007-0472-3","volume":"19","author":"Y Yamada","year":"2008","unstructured":"Yamada Y, Takahashi S, Fujimura T, Nishimatsu H, Ishikawa A, Kume H, et al. The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer. Osteoporos Int. 2008;19(3):321\u20137. doi: 10.1007\/s00198-007-0472-3 .","journal-title":"Osteoporos Int"},{"key":"83_CR102","doi-asserted-by":"crossref","unstructured":"Church DN, Hassan AB, Harper SJ, Wakeley CJ, Price CG. Osteomalacia as a late metabolic complication of Ifosfamide chemotherapy in young adults: illustrative cases and review of the literature. Sarcoma. 2007. 91586.","DOI":"10.1155\/2007\/91586"},{"issue":"2","key":"83_CR103","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2005.05.014","volume":"98","author":"L Duck","year":"2005","unstructured":"Duck L, Devogelaer JP, Persu A, Berliere M, Caussin E, Baurain JF, et al. Osteomalacia due to chemotherapy-induced Fanconi syndrome in an adult patient. Gynecol Oncol. 2005;98(2):329\u201331. doi: 10.1016\/j.ygyno.2005.05.014 .","journal-title":"Gynecol Oncol"},{"issue":"1","key":"83_CR104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","volume":"24","author":"PE Kintzel","year":"2001","unstructured":"Kintzel PE. Anticancer drug-induced kidney disorders. Drug Saf. 2001;24(1):19\u201338. doi: 10.2165\/00002018-200124010-00003 .","journal-title":"Drug Saf"},{"issue":"1","key":"83_CR105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiographics.14.1.8128043","volume":"14","author":"DA Bluemke","year":"1994","unstructured":"Bluemke DA, Fishman EK, Scott WW Jr. Skeletal complications of radiation therapy. Radiographics. 1994;14(1):111\u201321.","journal-title":"Radiographics"},{"issue":"3","key":"83_CR106","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00330-005-0010-7","volume":"16","author":"HJ Williams","year":"2006","unstructured":"Williams HJ, Davies AM. The effect of X-rays on bone: a pictorial review. Eur Radiol. 2006;16(3):619\u201333. doi: 10.1007\/s00330-005-0010-7 .","journal-title":"Eur Radiol"},{"issue":"3","key":"83_CR107","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mpo.10338","volume":"41","author":"JW Hopewell","year":"2003","unstructured":"Hopewell JW. Radiation-therapy effects on bone density. Med Pediatr Oncol. 2003;41(3):208\u201311. doi: 10.1002\/mpo.10338 .","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"83_CR108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1096-911X(199904)32:4<272::AID-MPO6>3.0.CO;2-G","volume":"32","author":"R Vassilopoulou-Sellin","year":"1999","unstructured":"Vassilopoulou-Sellin R, Brosnan P, Delpassand A, Zietz H, Klein MJ, Jaffe N. Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol. 1999;32(4):272\u20138. doi: 10.1002\/(SICI)1096-911X(199904) 32:4<272::AID-MPO6>3.0.CO;2-G .","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"83_CR109","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MED.0b013e3282f169b5","volume":"14","author":"RA Adler","year":"2007","unstructured":"Adler RA. Cancer treatment-induced bone loss. Curr Opin Endocrinol Diabetes Obes. 2007;14(6):442\u20135.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"83_CR110","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1148\/radiographics.18.5.9747611","volume":"18","author":"MJ Mitchell","year":"1998","unstructured":"Mitchell MJ, Logan PM. Radiation-induced changes in bone. Radiographics. 1998;18(5):1125\u201336. quiz 1242\u20133.","journal-title":"Radiographics"},{"issue":"20 Pt 2","key":"83_CR111","doi-asserted-by":"crossref","first-page":"6309s","DOI":"10.1158\/1078-0432.CCR-06-0652","volume":"12","author":"A Hirbe","year":"2006","unstructured":"Hirbe A, Morgan EA, Uluckan O, Weilbaecher K. Skeletal complications of breast cancer therapies. Clin Cancer Res. 2006;12(20 Pt 2):6309s\u201314. doi: 10.1158\/1078-0432.CCR-06-0652 .","journal-title":"Clin Cancer Res"},{"issue":"5","key":"83_CR112","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2214\/ajr.168.5.9129438","volume":"168","author":"RB Iyer","year":"1997","unstructured":"Iyer RB, Libshitz HI. Late sequelae after radiation therapy for breast cancer: imaging findings. AJR Am J Roentgenol. 1997;168(5):1335\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"83_CR113","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0360-3016(92)90895-O","volume":"23","author":"SM Pierce","year":"1992","unstructured":"Pierce SM, Recht A, Lingos TI, Abner A, Vicini F, Silver B, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23(5):915\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"83_CR114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/02841868809090331","volume":"27","author":"M Overgaard","year":"1988","unstructured":"Overgaard M. Spontaneous radiation-induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of fraction size and dose-response relationships on late bone damage. Acta Oncol (Stockholm, Sweden). 1988;27(2):117\u201322. doi: 10.3109\/02841868809090331 .","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"issue":"3","key":"83_CR115","first-page":"449","volume":"70","author":"M Bonfiglio","year":"1953","unstructured":"Bonfiglio M. The pathology of fracture of the femoral neck following irradiation. Am J Roentgenol Radium Ther Nucl Med. 1953;70(3):449\u201359.","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"3","key":"83_CR116","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2214\/ajr.137.3.585","volume":"137","author":"HI Libshitz","year":"1981","unstructured":"Libshitz HI, Edeiken BS. Radiotherapy changes of the pediatric hip. AJR Am J Roentgenol. 1981;137(3):585\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"83_CR117","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2214\/ajr.177.5.1771083","volume":"177","author":"RB Iyer","year":"2001","unstructured":"Iyer RB, Jhingran A, Sawaf H, Libshitz HI. Imaging findings after radiotherapy to the pelvis. AJR Am J Roentgenol. 2001;177(5):1083\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"83_CR118","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/ctrv.2000.0180","volume":"26","author":"BL Leeuwen van","year":"2000","unstructured":"van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ. The effect of chemotherapy on the growing skeleton. Cancer Treat Rev. 2000;26(5):363\u201376. doi: 10.1053\/ctrv.2000.0180 .","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"83_CR119","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archinte.165.5.552","volume":"165","author":"Z Chen","year":"2005","unstructured":"Chen Z, Maricic M, Bassford TL, Pettinger M, Ritenbaugh C, Lopez AM, et al. Fracture risk among breast cancer survivors: results from the Women\u2019s Health Initiative Observational Study. Arch Intern Med. 2005;165(5):552\u20138. doi: 10.1001\/archinte.165.5.552 .","journal-title":"Arch Intern Med"},{"issue":"11","key":"83_CR120","doi-asserted-by":"crossref","first-page":"2739S","DOI":"10.1093\/jn\/135.11.2739S","volume":"135","author":"MF Holick","year":"2005","unstructured":"Holick MF. The vitamin D epidemic and its health consequences. J Nutr. 2005;135(11):2739S\u201348.","journal-title":"J Nutr"},{"issue":"3","key":"83_CR121","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266\u201381. doi: 10.1056\/NEJMra070553 .","journal-title":"N Engl J Med"},{"issue":"2","key":"83_CR122","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/beem.2000.0074","volume":"14","author":"IR Reid","year":"2000","unstructured":"Reid IR. Glucocorticoid-induced osteoporosis. Best Pract Res Clin Endocrinol Metab. 2000;14(2):279\u201398. doi: 10.1053\/beem.2000.0074 .","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"83_CR123","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/10428190701268775","volume":"48","author":"R Ria","year":"2007","unstructured":"Ria R, Scarponi AM, Falzetti F, Ballanti S, Di Ianni M, Sportoletti P, et al. Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation. Leuk Lymphoma. 2007;48(5):923\u201330. doi: 10.1080\/10428190701268775 .","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"83_CR124","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1399-0012.2003.00047.x","volume":"17","author":"J Heaf","year":"2003","unstructured":"Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N. Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transpl. 2003;17(3):268\u201374. doi: 10.1034\/j.1399-0012.2003.00047.x .","journal-title":"Clin Transpl"},{"issue":"4","key":"83_CR125","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1590\/S0004-27302006000400023","volume":"50","author":"CA Kulak","year":"2006","unstructured":"Kulak CA, Borba VZ, Kulak Junior J, Shane E. Transplantation osteoporosis. Arq Bras Endocrinol Metabol. 2006;50(4):783\u201392. doi: 10.1590\/S0004-27302006000400023 .","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"83_CR126","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/1097-0142(197509)36:3<1111::AID-CNCR2820360341>3.0.CO;2-9","volume":"36","author":"IB Rosen","year":"1975","unstructured":"Rosen IB, Strawbridge HG, Bain J. A case of hyperparathyroidism associated with radiation to the head and neck area. Cancer. 1975;36(3):1111\u20134. doi: 10.1002\/1097-0142(197509)36:3<1111::AID-CNCR2820360341>3.0.CO;2-9 .","journal-title":"Cancer"},{"issue":"9","key":"83_CR127","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/bjs.1800750914","volume":"75","author":"TJ Christmas","year":"1988","unstructured":"Christmas TJ, Chapple CR, Noble JG, Milroy EJ, Cowie AG. Hyperparathyroidism after neck irradiation. Br J Surg. 1988;75(9):873\u20134. doi: 10.1002\/bjs.1800750914 .","journal-title":"Br J Surg"},{"issue":"6","key":"83_CR128","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.surg.2007.08.010","volume":"142","author":"G Ippolito","year":"2007","unstructured":"Ippolito G, Palazzo FF, Sebag F, Henry JF. Long-term follow-up after parathyroidectomy for radiation-induced hyperparathyroidism. Surgery. 2007;142(6):819\u201322. discussion 822 e1.","journal-title":"Surgery"},{"issue":"5","key":"83_CR129","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP.9.5.353","volume":"9","author":"B Kalaghchi","year":"2003","unstructured":"Kalaghchi B, Brietzke SA, Drake AJ 3rd, Shakir KM. Effects of prior neck radiation therapy on clinical features of primary hyperparathyroidism and associated thyroid tumors. Endocr Pract. 2003;9(5):353\u201362.","journal-title":"Endocr Pract"},{"issue":"2","key":"83_CR130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1099800407308057","volume":"9","author":"PT Alpert","year":"2007","unstructured":"Alpert PT, Shaikh U. The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems. Biol Res Nurs. 2007;9(2):117\u201329. doi: 10.1177\/1099800407308057 .","journal-title":"Biol Res Nurs"},{"issue":"4","key":"83_CR131","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1590\/S0004-27302006000400009","volume":"50","author":"F Bandeira","year":"2006","unstructured":"Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E. Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006;50(4):640\u20136.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"6163","key":"83_CR132","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bmj.1.6163.589","volume":"1","author":"MR Baker","year":"1979","unstructured":"Baker MR, McDonnell H, Peacock M, Nordin BE. Plasma 25-hydroxy vitamin D concentrations in patients with fractures of the femoral neck. Br Med J. 1979;1(6163):589.","journal-title":"Br Med J"},{"issue":"6","key":"83_CR133","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2004-2364","volume":"90","author":"MF Holick","year":"2005","unstructured":"Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90(6):3215\u201324. doi: 10.1210\/jc.2004-2364 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"83_CR134","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bone.2007.09.042","volume":"42","author":"Y Kinoshita","year":"2008","unstructured":"Kinoshita Y, Masuoka K, Miyakoshi S, Taniguchi S, Takeuchi Y. Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy. Bone. 2008;42(1):226\u20138. doi: 10.1016\/j.bone.2007.09.042 .","journal-title":"Bone"},{"issue":"5","key":"83_CR135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0009922807311732","volume":"47","author":"VC Cohran","year":"2008","unstructured":"Cohran VC, Griffiths M, Heubi JE. Bone mineral density in children exposed to chronic glucocorticoid therapy. Clin Pediatr. 2008;47(5):469\u201375. doi: 10.1177\/0009922807311732 .","journal-title":"Clin Pediatr"},{"issue":"19","key":"83_CR136","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa051140","volume":"354","author":"E Berman","year":"2006","unstructured":"Berman E, Nicolaides M, Maki RG, Fleisher M, Chanel S, Scheu K, et al. Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med. 2006;354(19):2006\u201313. doi: 10.1056\/NEJMoa051140 .","journal-title":"N Engl J Med"},{"issue":"23","key":"83_CR137","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1056\/NEJMc062388","volume":"355","author":"A Grey","year":"2006","unstructured":"Grey A, O\u2019Sullivan S, Reid IR, Browett P. Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism. N Engl J Med. 2006;355(23):2494\u20135. doi: 10.1056\/NEJMc062388 .","journal-title":"N Engl J Med"},{"issue":"5","key":"83_CR138","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ajh.20778","volume":"82","author":"S Osorio","year":"2007","unstructured":"Osorio S, Noblejas AG, Duran A, Steegmann JL. Imatinib mesylate induces hypophosphatemia in patients with chronic myeloid leukemia in late chronic phase, and this effect is associated with response. Am J Hematol. 2007;82(5):394\u20135. doi: 10.1002\/ajh.20778 .","journal-title":"Am J Hematol"},{"issue":"1","key":"83_CR139","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1634\/theoncologist.12-1-107","volume":"12","author":"EP Rock","year":"2007","unstructured":"Rock EP, Goodman V, Jiang JX, Mahjoob K, Verbois SL, Morse D, et al. Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma. Oncologist. 2007;12(1):107\u201313. doi: 10.1634\/theoncologist.12-1-107 .","journal-title":"Oncologist"},{"issue":"24","key":"83_CR140","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1158\/1078-0432.CCR-06-1249","volume":"12","author":"RC Kane","year":"2006","unstructured":"Kane RC, Farrell AT, Saber H, Tang S, Williams G, Jee JM, et al. Sorafenib for the treatment of advanced renal cell carcinoma. Clin Cancer Res. 2006;12(24):7271\u20138. doi: 10.1158\/1078-0432.CCR-06-1249 .","journal-title":"Clin Cancer Res"},{"issue":"1","key":"83_CR141","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S8756-3282(00)00404-X","volume":"28","author":"JT Heiskanen","year":"2001","unstructured":"Heiskanen JT, Kroger H, Paakkonen M, Parviainen MT, Lamberg-Allardt C, Alhava E. Bone mineral metabolism after total gastrectomy. Bone. 2001;28(1):123\u20137. doi: 10.1016\/S8756-3282(00)00404-X .","journal-title":"Bone"},{"issue":"4","key":"83_CR142","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9610(97)00123-2","volume":"174","author":"TT Zittel","year":"1997","unstructured":"Zittel TT, Zeeb B, Maier GW, Kaiser GW, Zwirner M, Liebich H, et al. High prevalence of bone disorders after gastrectomy. Am J Surg. 1997;174(4):431\u20138. doi: 10.1016\/S0002-9610(97) 00123-2 .","journal-title":"Am J Surg"},{"issue":"8","key":"83_CR143","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00042737-200308000-00006","volume":"15","author":"C Tirpitz von","year":"2003","unstructured":"von Tirpitz C, Reinshagen M. Management of osteoporosis in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol. 2003;15(8):869\u201376. doi: 10.1097\/00042737-200308000-00006 .","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"83_CR144","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0016-5085(80)90137-7","volume":"79","author":"M Imawari","year":"1980","unstructured":"Imawari M, Kozawa K, Akanuma Y, Koizumi S, Itakura H, Kosaka K. Serum 25-hydroxyvitamin D and vitamin D-binding protein levels and mineral metabolism after partial and total gastrectomy. Gastroenterology. 1980;79(2):255\u20138.","journal-title":"Gastroenterology"},{"issue":"11","key":"83_CR145","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/gut.32.11.1303","volume":"32","author":"S Bisballe","year":"1991","unstructured":"Bisballe S, Eriksen EF, Melsen F, Mosekilde L, Sorensen OH, Hessov I. Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut. 1991;32(11):1303\u20137. doi: 10.1136\/gut.32.11.1303 .","journal-title":"Gut"},{"issue":"1","key":"83_CR146","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03345523","volume":"28","author":"EC Naliato","year":"2005","unstructured":"Naliato EC, Farias ML, Braucks GR, Costa FS, Zylberberg D, Violante AH. Prevalence of osteopenia in men with prolactinoma. J Endocrinol Invest. 2005;28(1):12\u20137.","journal-title":"J Endocrinol Invest"},{"issue":"48","key":"83_CR147","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.3748\/wjg.v13.i48.6492","volume":"13","author":"JS Lim","year":"2007","unstructured":"Lim JS, Kim SB, Bang HY, Cheon GJ, Lee JI. High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy. World J Gastroenterol. 2007;13(48):6492\u20137. doi: 10.3748\/wjg.13.6492 .","journal-title":"World J Gastroenterol"},{"issue":"1","key":"83_CR148","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/gye.15.1.43.47","volume":"15","author":"P Vartej","year":"2001","unstructured":"Vartej P, Poiana C, Vartej I. Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women. Gynecol Endocrinol. 2001;15(1):43\u20137. doi: 10.1080\/713602650 .","journal-title":"Gynecol Endocrinol"},{"key":"83_CR149","doi-asserted-by":"crossref","unstructured":"Shibli-Rahhal A, Schlechte J. The effects of hyperprolactinemia on bone and fat. Pituitary. 2008.","DOI":"10.1007\/s11102-008-0097-3"},{"issue":"11","key":"83_CR150","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1200\/JCO.1987.5.11.1841","volume":"5","author":"LS Constine","year":"1987","unstructured":"Constine LS, Rubin P, Woolf PD, Doane K, Lush CM. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies. J Clin Oncol. 1987;5(11):1841\u201351.","journal-title":"J Clin Oncol"},{"issue":"2","key":"83_CR151","first-page":"116","volume":"58","author":"B Zadrozna-Sliwka","year":"2007","unstructured":"Zadrozna-Sliwka B, Bolanowski M, Kaluzny M, Syrycka J. Bone mineral density and bone turnover in hyperprolactinaemia of various origins. Endokrynol Pol. 2007;58(2):116\u201322.","journal-title":"Endokrynol Pol"},{"issue":"5","key":"83_CR152","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0360-3016(94)00427-M","volume":"31","author":"CA Sklar","year":"1995","unstructured":"Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1113\u201321. doi: 10.1016\/0360-3016(94)00427-M .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3\u20134","key":"83_CR153","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-006-6042-4","volume":"8","author":"KH Darzy","year":"2005","unstructured":"Darzy KH, Shalet SM. Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary. 2005;8(3\u20134):203\u201311. doi: 10.1007\/s11102-006-6042-4 .","journal-title":"Pituitary"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-009-0083-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-009-0083-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-009-0083-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T08:00:50Z","timestamp":1739088050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-009-0083-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,2]]},"references-count":153,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["83"],"URL":"https:\/\/doi.org\/10.1007\/s11764-009-0083-4","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,2]]}}}